Eastman Chemical Co. is gearing up to introduce its MXF221 copolyester to the Chinese market. Offering superior chemical resistance, use of the resin product for housing medical devices can enhance...
medical
Taiyo Holdings Looks to Produce Drugs In-House
Taiyo Holdings Co. Ltd. (TYO:4626) has acquired long-listed drug business operations from Chugai Pharmaceutical Co. Ltd. (TYO:4519), and plans to acquire its own factory within the fiscal year to produce...
NISRI’s Chubu Technology Licensing Office Nears Real-World Applications for Spider Silk
The Nagoya Industrial Science Research Institute (NISRI) Chubu Technology Licensing Office (TLO) is bringing the practical use of spider silk closer to reality. The Chubu TLO is collaborating with Kurabo...
Interview: Pfizer Japan President Akihisa Harada Talks Business, New Drug Developments
Pfizer Japan Inc. last December saw a changing of the guard as Akihisa Harada, head of the Japanese branch’s Inflammation & Immunology unit, stepped in to take over from Ichiro...
Riken and Ricoh Prototype Artificial Bone With 3D Printing
A research group composed of members from the Institute of Physical and Chemical Research (Riken) and Ricoh Co. Ltd. (TYO:7752) has used 3D printing to develop a strong artificial bone...
Chuetsu Teams With Universities to Develop CNF for Medical, Resin Applications
Chuetsu Pulp & Paper Co. Ltd. (TYO:3877) is partnering with universities to augment research and development into cellulose nanofiber (CNF). As part of this, the company is working with the...
Memory T Cells Found to Alter Immunological Response Based on Intensity of Antigenic Stimulation
An international research group formed by the Institute of Physical and Chemical Research (Riken), Osaka University and Yale University has discovered that the strength at which memory T cells are...
NOF Develops Monodisperse PEG for Antibody Drug Delivery
NOF Corp. (TYO:4403) has developed a monodisperse polyethylene glycol (PEG) as a drug delivery system (DDS) material usable in antibody drugs. Sales of the PEG began in March. Unlike typical...
Eisai Plans Entry Into Nucleic Acid Drug Market
Eisai Co. Ltd. (TYO:4523) is gearing up to make a full-fledged entry into the nucleic acid drug market. Leveraging tie-ups with academia and contract manufacturing organizations (CMOs) in the industry,...
Interview: Meiji Seika Pharma President Talks Drug Pricing Reform, Business Targets
Meiji Seika Pharma Co. Ltd. is transitioning in more ways than one as of late, not only adjusting to new criteria under Japan’s drug pricing system but also getting ready...
Nippon Shinyaku Targets 2019 Approval for New Muscular Dystrophy Treatment
Nippon Shinyaku Co. Ltd. (TYO:4516) has completed Phase 2 clinical trials in the U.S. for NS-065 as of this February. Japan’s first anti-sense nucleic acid medicine, NS-065 was created as...
Interview: Nippon Shokubai President Yujiro Goto Talks Shift Into New Business Areas
Nippon Shokubai Co. Ltd. (TYO:4114) has been actively refocusing its efforts under its “Reborn Nippon Shokubai 2020” long-term business plan. Company president Yujiro Goto recently sat down with The Chemical...
Mitsubishi Chemical Holdings to Use New Method of Creating Health Care Businesses
Mitsubishi Chemical Holdings Corp. (TYO:4188) is planning to create health care businesses using a new method called Biodesign. As part of this plan, the company will soon establish specialized teams...
Nihon Medi-Physics Embarks on Development of New Cancer Treatment
Nihon Medi-Physics Co. Ltd., a radiopharmaceutical manufacturing venture equally funded by Sumitomo Chemical Co. Ltd. (TYO:4005) and GE Healthcare, will begin working toward the establishment of theranostics – a completely...
Hitachi Chemical Plans European Medical Supplies Base
Hitachi Chemical Co. Ltd. (TYO:4217) will establish a European contract development and manufacturing organization (CDMO) for medical supplies within fiscal 2018. This comes as part of a company plan to...
Mitsui Partners with Thorne Research in Presymptomatic Disease Business
Mitsui & Co. Ltd. (TYO:8031) has formed a strategic alliance with U.S. supplement maker Thorne Research Inc. that involves an investment of around 1 billion yen ($8.84 million) and will...
Toppan Printing, Kotobuki Giken Develop Vegetable-Based Artificial Organs for Surgical Training
Toppan Printing Co. Ltd. (TYO:7911) and medical peripheral company Kotobuki Giken Inc. recently announced that they have used vegetable materials to create new artificial organs for surgical training. The products...
Toray Moves Closer to Chinese Launch of Mass Market Dialyzers
Toray Industries Inc. (TYO:3402) is expanding its dialysis business in China. The company received approval from the China Food and Drug Administration (CFDA) to sell mass market dialyzers, or artificial...
Interview: Olympus CEO Discusses Strategy for Company’s Medical Solutions
As a top medical device manufacturer in Japan, Olympus Corp. (TYO:7733) has now set its sights on becoming a top player in the global medical field. The Chemical Daily recently...
AIST Develops Protein Micromachine for Eliminating Reactive Oxygen Species
The National Institute of Advanced Industrial Science and Technology (AIST) has developed a protein micromachine that eliminates harmful reactive oxygen species (ROS) in the human body. Excessive levels of ROS...
